🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In clinical practice, some patients cannot tolerate concurrent chemoradioth...
Status
Recruiting
Location
Zibo Municipal Hospital
Start Date
2024-01-13
Trial ID
NCT07085182
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2005-01
Trial ID
NCT00031629
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
This is an open label, phase II study to evaluate the capacity of Rituximab...
Status
Completed
Location
AKH Linz
Start Date
2012-05
Trial ID
NCT01611259
Treatments Being Tested
The purpose of this trial is to estimate the therapeutic efficacy of the ex...
Status
Suspended
Location
Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gesundheitszentrum St. Marien GmbH
Start Date
2010-04
Trial ID
NCT01088620
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of n...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-25
Trial ID
NCT07272291
Treatments Being Tested
In relapsing remitting multiple sclerosis (RRMS) the relationship between c...
Status
Completed
Location
Eman Khedr
Start Date
2022-03-01
Trial ID
NCT05604092
The purpose of this study is to assess the tolerability and efficacy of ran...
Status
Completed
Location
Texas Retina Associates
Start Date
2014-09-23
Trial ID
NCT02222610
Treatments Being Tested
TITAN RCC (0216-ASG) is a Phase 2, open-label study of nivolumab monotherap...
Status
Completed
Location
Ordensklinikum Linz Barmherzige Schwestern
Start Date
2016-10
Trial ID
NCT02917772
Treatments Being Tested